文献速递衰弱、肌少症与跌倒老年慢病共病管理

社区人群按EWGSOP2定义的肌少症患病率与临床特征

Sarcopenia Identified According to the EWGSOP2 Definition in Community-Living People: Prevalence and Clinical Features.
PubMed 文献 · J Am Med Dir Assoc · 2020-04-28

该横断面研究基于Longevity Check-up 7+项目,在展览、商场等非传统场所纳入11253名18至98岁社区人群,采用握力和椅子站立试验按EWGSOP2算法评估肌少症。结果973人(8.6%)被识别为肌少症,患病率随年龄显著增加,并与糖尿病、400米步行能力受损及自报不健康状态相关,健康饮食和规律体力活动者肌少症概率较低。

要点

  • 社区人群按EWGSOP2算法肌少症患病率为8.6%,且随年龄增长显著升高。
  • 糖尿病、400米步行能力受损及自报不健康状态与肌少症风险升高相关。
  • 健康饮食和规律体力活动与肌少症概率降低相关,推荐用握力和椅子站立试验早期筛查。

核心结论

  • 社区人群中按EWGSOP2定义识别的肌少症患病率为8.6%,且随年龄增长而显著升高。
  • 肌少症与糖尿病、400米步行能力受损及自报不健康状态相关,健康饮食和规律体力活动者肌少症概率较低。
  • 推荐将肌力与躯体功能评估用于 probable sarcopenia 风险个体的早期识别。

研究设计与样本

  • Longevity Check-up 7+项目为2015年6月启动的持续横断面研究,在展览、商场和健康促进活动等非传统场所开展。
  • 纳入年龄至少18岁的候选参与者,共分析11253名受试者,平均年龄55.6岁(标准差11.5,范围18至98岁),女性6356人(56%)。
  • 肌力采用握力评估,躯体功能采用椅子站立试验评估,按EWGSOP2算法判定肌少症。

主要发现

  • 973名参与者(8.6%)按EWGSOP2算法被识别为肌少症,患病率随年龄显著增加。
  • 肌少症与糖尿病患病率比(PR)1.42(95%CI 1.06-1.89)相关。
  • 肌少症与400米步行能力受损相关(PR 2.16,95%CI 1.74-2.17),与自报不健康状态相关(PR 1.77,95%CI 1.45-2.17)。
  • 健康饮食者肌少症概率降低(PR 0.79,95%CI 0.63-0.98),规律体力活动者肌少症概率降低(PR 0.79,95%CI 0.64-0.99)。

关键数值与推荐

  • EWGSOP2算法判定肌少症:采用握力评估肌力、椅子站立试验评估躯体功能。
  • 肌少症患病率8.6%(973/11253),患病率随年龄显著增加。
  • 糖尿病PR 1.42(95%CI 1.06-1.89);400米步行能力受损PR 2.16(95%CI 1.74-2.17);自报不健康状态PR 1.77(95%CI 1.45-2.17)。
  • 健康饮食PR 0.79(95%CI 0.63-0.98);规律体力活动PR 0.79(95%CI 0.64-0.99)。

临床怎么用

  • 在社区老年人群中可采用握力和椅子站立试验进行肌少症早期筛查。
  • 对合并糖尿病、步行能力受损或自报不健康状态者应关注肌少症风险。
  • 健康饮食和规律体力活动与较低肌少症概率相关,可作为健康促进参考。

局限性

  • 横断面设计无法推断因果关系。
  • 研究在展览、商场和健康促进活动等非传统场所开展,样本可能不能完全代表一般社区人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The European Working Group on Sarcopenia in Older People (EWGSOP2) recently updated the definition of sarcopenia in order to reflect scientific and clinical evidences. OBJECTIVE: The aim is to explore the prevalence of sarcopenia (according to the new EWGSOP2 definition) and related risk factors among an unselected sample of subjects living in community. SETTING AND PARTICIPANTS: The Longevity Check-up 7+ project is an ongoing cross-sectional study started in June 2015 and conducted in unconventional settings (ie, exhibitions, malls, and health promotion campaigns). Candidate participants are eligible for enrollment if they are at least 18 years of age. METHODS: Muscle strength was assessed by handgrip strength and physical performance was evaluated by chair stand test. RESULTS: The mean age of 11,253 subjects was 55.6 (standard deviation 11.5, from 18 to 98 years) years, and 6356 (56%) were women. Using the EWGSOP2 algorithm, 973 participants (8.6%) were identified as affected by sarcopenia, and the prevalence of sarcopenia significantly increased with age. Sarcopenia was associated with diabetes prevalence ratio (PR) 1.42, 95% confidence interval (CI) 1.06-1.89, impairment in 400-m walking performance (PR 2.16, 95% CI 1.74-2.17), and self-reported unhealthy status (PR 1.77, 95% CI 1.45-2.17). Conversely, a decreased probability of being sarcopenic was detected among subjects following a healthy diet (PR 0.79, 95% CI 0.63-0.98) and involved in regular physical activity (PR 0.79, 95% CI 0.64-0.99). CONCLUSIONS AND IMPLICATIONS: Muscle strength and physical performance assessment should be considered as the recommended methods for the early detection of individuals at risk of probable sarcopenia.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Martone AM, Marzetti E, Salini S, et al. Sarcopenia Identified According to the EWGSOP2 Definition in Community-Living People: Prevalence and Clinical Features. J Am Med Dir Assoc. 2020. PMID: 32359893. doi:10.1016/j.jamda.2020.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。